| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism P Gao, I Tchernyshyov, TC Chang, YS Lee, K Kita, T Ochi, KI Zeller, ... Nature 458 (7239), 762-765, 2009 | 2389 | 2009 |
| Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology: a scientific statement from the American … P Kligfield, LS Gettes, JJ Bailey, R Childers, BJ Deal, EW Hancock, ... Circulation 115 (10), 1306-1324, 2007 | 1705 | 2007 |
| How many human proteoforms are there? R Aebersold, JN Agar, IJ Amster, MS Baker, CR Bertozzi, ES Boja, ... Nature chemical biology 14 (3), 206-214, 2018 | 887 | 2018 |
| Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide FD Sonnichsen, JE Van Eyk, RS Hodges, BD Sykes Biochemistry 31 (37), 8790-8798, 1992 | 791 | 1992 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 647 | 2018 |
| Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 JE Ebinger, J Fert-Bober, I Printsev, M Wu, N Sun, JC Prostko, EC Frias, ... Nature medicine 27 (6), 981-984, 2021 | 602 | 2021 |
| Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane W Xu, Y Liu, S Wang, T McDonald, JE Van Eyk, A Sidor, B O'Rourke Science 298 (5595), 1029-1033, 2002 | 596 | 2002 |
| Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ... Molecular & Cellular Proteomics 13 (3), 907-917, 2014 | 578 | 2014 |
| Guidelines for experimental models of myocardial ischemia and infarction ML Lindsey, R Bolli, JM Canty Jr, XJ Du, NG Frangogiannis, S Frantz, ... American Journal of Physiology-Heart and Circulatory Physiology 314 (4 …, 2018 | 523 | 2018 |
| Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications GD Vatine, R Barrile, MJ Workman, S Sances, BK Barriga, M Rahnama, ... Cell stem cell 24 (6), 995-1005. e6, 2019 | 517 | 2019 |
| Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm ME Lindsay, D Schepers, NA Bolar, JJ Doyle, E Gallo, J Fert-Bober, ... Nature genetics 44 (8), 922-927, 2012 | 504 | 2012 |
| Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized … KA Ellenbogen, MR Gold, TE Meyer, I Fernndez Lozano, S Mittal, ... Circulation 122 (25), 2660-2668, 2010 | 486 | 2010 |
| Preparation of proteins and peptides for mass spectrometry analysis in a bottom‐up proteomics workflow RL Gundry, MY White, CI Murray, LA Kane, Q Fu, BA Stanley, JE Van Eyk Current protocols in molecular biology 90 (1), 10.25. 1-10.25. 23, 2010 | 440 | 2010 |
| A mass spectrometric-derived cell surface protein atlas D Bausch-Fluck, A Hofmann, T Bock, AP Frei, F Cerciello, A Jacobs, ... PloS one 10 (4), e0121314, 2015 | 439 | 2015 |
| Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction R Labugger, L Organ, C Collier, D Atar, JE Van Eyk Circulation 102 (11), 1221-1226, 2000 | 428 | 2000 |
| The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations AB Keenan, SL Jenkins, KM Jagodnik, S Koplev, E He, D Torre, Z Wang, ... Cell systems 6 (1), 13-24, 2018 | 425 | 2018 |
| Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury JL McDonough, DK Arrell, JE Van Eyk Circulation research 84 (1), 9-20, 1999 | 414 | 1999 |
| Guidelines for the next 10 years of proteomics MR Wilkins, RD Appel, JE Van Eyk, MCM Chung, A Görg, M Hecker, ... Proteomics 6 (1), 4-8, 2006 | 390 | 2006 |
| Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease DI Lee, G Zhu, T Sasaki, GS Cho, N Hamdani, R Holewinski, SH Jo, ... Nature 519 (7544), 472-476, 2015 | 373 | 2015 |
| Clinical proteomics: a need to define the field and to begin to set adequate standards H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ... PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007 | 361 | 2007 |
